# Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland

> **NCT01100853** · PHASE3 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 100 (actual)

## Conditions studied

- Amphetamine Dependence

## Interventions

- **DRUG:** VIVITROL injection and VIVITROL Placebo Injection , 24 weeks

## Key facts

- **NCT ID:** NCT01100853
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01100853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01100853, "Extended Release Naltrexone for Treating Amphetamine Dependence in Iceland". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01100853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*